Thematic Articles Open access

Operational research as an instrument to address the critical gaps for effective treatment of tuberculosis in eastern Europe and central Asia

Authors

Published
14 January 2021
Section
Thematic Articles
DOI
10.4081/monaldi.2021.1736

Abstract

Editorial

Keywords

References

  1. Global tuberculosis report 2020. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/336069).
  2. Coronavirus Disease (COVID-19) Dashboard. Geneva: World Health Organization; 2020 [website] (https://covid19.who.int/).
  3. Clinical management of COVID-19: interim guidance, 27 May 2020. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/332196).
  4. Dara M, Sotgiu G, Reichler M R. et al. New diseases and old threats: lessons from tuberculosis for the COVID-19 response. Int J Tubercul Lung Dis 2020;24;544-5.
  5. United Nations Sustainable Development. Transforming our world: the 2030 Agenda for Sustainable Development. 2014 [website] (https://sustainabledevelopment.un.org/post2015/transformingourworld).
  6. WHO Regional Office for Europe, European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2020–2018 data. Copenhagen, Stockholm: WHO Regional Office for Europe and European Centre for Disease Prevention and Control; 2020 (https://apps.who.int/iris/handle/10665/331530).
  7. Dadu A, Hovhannesyan A, Ahmedov S, et al. Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data. Lancet Infect Dis 2019;20:250-8.
  8. The end TB Strategy. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/handle/10665/331326).
  9. Moscow Declaration to End TB. Geneva: World Health Organization; 2017. (https://www.who.int/tb/features_archive/Moscow_Declaration_to_End_TB_final_ENGLISH.pdf?ua=1).
  10. Global Strategy for Tuberculosis Research and Innovation. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/336076).
  11. Process Overview: Development of a Global Strategy for TB Research and Innovation. World Health Organization; 2020[website] (https://www.who.int/tb/features_archive/Process-Global-strategy-for-TB-research-innovation/en/).
  12. Member States adopt the Global Strategy for TB Research and Innovation at 73rd World Health Assembly [website]. World Health Organization; 2020. (https://www.who.int/news/item/10-08-2020-member-states-adopt-the-global-strategy-for-tb-research-and-innovation-at-73rd-world-health-assembly#:~:text=World%20Health%20Assembly-).
  13. The WHO strategy on research for health. Geneva: World Health Organization; 2012. (https://apps.who.int/iris/handle/10665/77935).
  14. WHO Regional Office for Europe. Evidence-informed policymaking. Copenhagen: WHO Regional Office for Europe; 2020 (https://www.euro.who.int/en/data-and-evidence/evidenceinformed-policy-making/evidence-informed-policy-making).
  15. European Programme of Work, 2020–2025 – “United Action for Better Health in Europeâ€. 70th session of the Regional Committee for Europe. Copenhagen: WHO Regional Office for Europe; 2020 (Document: EUR/RC70/11 Rev.4; https://www.euro.who.int/en/about-us/governance/regional-committee-foreurope/70th-session/documentation/working-documents/eurrc7011-rev.4-european-programme-of-work-20202025-unitedaction-for-better-health-in-europe).
  16. Structured operational research training of the European Tuberculosis Research Initiative: workshops 1 and 2 of 4 [website]. Copenhagen: WHO Regional Office for Europe; 2018. (https://www.euro.who.int/en/media-centre/events/events/2018/10/structured-operational-research-training-of-the-europeantuberculosis-rsearch-initiative-workshops-1-and-2-of-4).
  17. Defining the tuberculosis research agenda for the WHO European Region: a study report of the European TB Research Initiative. Copenhagen: WHO Regional Office for Europe; 2019 (https://apps.who.int/iris/handle/10665/327085).
  18. Tuberculosis and drug-resistant tuberculosis in eastern Europe: operational research from the SORT IT Programme, 2012–2014. Public Health Action 2014;4 (Suppl 2) [website]. Copenhagen: WHO Regional Office for Europe; 2014 (https://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/news/news/2014/10/supplement-tuberculosis-and-drug-resistant-tuberculosis-in-eastern-europe-operational-research-from-the-sort-it-programme,-20122014-just-published).
  19. Gogichadze N, Kuchukhidze G, Merabishvili T, Tsereteli M. et al. Poor follow-up of paediatric tuberculosis contacts in Tbilisi, Georgia. Public Health Panorama 2019;5:447-51 (https://apps.who.int/iris/handle/10665/330190).
  20. Kabasakalyan E, Davtyan K, et al. A cross-sectional study of the turnaround time of Armenia’s national tuberculosis programme laboratory services in 2017–2018. Public Health Panorama 2019;5:459-66 (https://apps.who.int/iris/handle/10665/330192).
  21. Korotych O, Hovhannisyan A, et al. Risk factors associated with MDR/RR-TB among new pulmonary tuberculosis patients in urban and rural areas of Ukraine in 2017: retrospective analysis of routine surveillance data. Public Health Panorama 2019;5:536-47 (https://apps.who.int/iris/handle/10665/330200).
  22. Kabasakalyan E, Khachatryan A, et al. Underreporting of diagnosed tuberculosis cases to the national surveillance system in Armenia in 2017. Public Health Panorama 2019;5:476-83 (https://apps.who.int/iris/handle/10665/330194) .
  23. A people-centred model of TB care: Blueprint for EECA countries, first edition. Copenhagen: WHO Regional Office for Europe; 2017. (https://www.euro.who.int/__data/assets/pdf_file/0004/342373/TB_Content_WHO_PRO_eng_final.pdf).
  24. WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/332397).
  25. Ciobanu A, Plesca V, et al. Assessment of multidrug- resistant tuberculosis associated catastrophic costs incurred by families/households in the Republic of Moldova. 2017 (project report). (https://www.researchgate.net/pub- lication/321051278_Assessment_of_multidrug-resistant_tuber- culosis_associated_catastrophic_costs_incurred_by_fami- lieshouseholds_in_the_Republic_of_Moldova).
  26. Duko B, Bedaso A, Ayano G. The prevalence of depression among patients with tuberculosis: A systematic review and metaanalysis. Ann Gen Psychiatry 2020;19:30 (https://annals-generalpsychiatry.biomedcentral.com/articles/10.1186/s12991-020-00281-8).
  27. Psychosocial support for people with TB, HIV and viral hepatitis in the continuum of care in the WHO European Region: Report, July 2020. Copenhagen: WHO Regional Office for Europe; 2020 (https://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/publications/2020/psychosocial-support-forpeople-with-tb,-hiv-and-viral-hepatitis-in-the-continuum-ofcare-in-the-who-european-region.-report-july-2020).
  28. Borisov S, Danila E, Maryandyshev A, et al. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report. Eur Respir J 2019;54:1901522.

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.